Krebs Biochemicals & Industries Limited (BSE: 524518)
Health Care · Pharmaceuticals · IN
Rs54.47
-2.56% today · -25.7% 1Y
Krebs Biochemicals & Industries Limited (BSE: 524518) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.27M.
Over the last twelve months the share price has lost 25.7%, trading between 38.52 and 81.80.
Tweenvest scores Krebs Biochemicals & Industries Limited across four factors: quality 29/100, value 63/100, growth 0/100. Its strongest factor is value.
524518 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.27M
- Revenue (TTM)
- $2.67M
- P/E
- —
- EPS
- -6.53
- Dividend yield
- —
- Beta (5Y)
- 0.86
- 52-week high
- Rs81.80
- 52-week low
- Rs38.52
- Avg volume (3M)
- —
- Shares outstanding
- 21.56M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.